Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis.

Purpose of reviewWhile Pseudomonas aeruginosa continues to be the major pathogen in cystic fibrosis lung disease, there is increasing evidence that antibiotic therapy initiated early after the onset of infection is an effective strategy to postpone chronic P. aeruginosa infection. There are also stu